Literature DB >> 19887484

Activation of host wound responses in breast cancer microenvironment.

Melissa A Troester1, Myung Hee Lee, Matthew Carter, Cheng Fan, David W Cowan, Erick Roman Perez, Jason R Pirone, Charles M Perou, D Joseph Jerry, Sallie Smith Schneider.   

Abstract

PURPOSE: Cancer progression is mediated by processes that are also important in wound repair. As a result, cancers have been conceptualized as overhealing wounds or "wounds that do not heal," and gene expression signatures reflective of wound repair have shown value as predictors of breast cancer survival. Despite the widespread acknowledgment of commonalities between host responses to wounds and host responses to cancer, the gene expression responses of normal tissue adjacent to cancers have not been well characterized. EXPERIMENTAL
DESIGN: Using RNA extracted from histologically normal breast tissue from 107 patients, including 60 reduction mammoplasty patients and 47 cancer patients, we measured whole genome expression profiles and identified a gene expression signature that is induced in response to breast cancer.
RESULTS: This signature represents an in vivo "wound response" signature that is differentially expressed in the normal tissue of breast cancer patients compared with those without disease and is highly accurate (at least 92% sensitivity and 98% specificity) in distinguishing diseased and nondiseased. The in vivo wound response signature is highly prognostic of breast cancer survival, and there is a strong association between the groups identified by this signature and those identified using serum-treated fibroblasts and other microenvironment-derived or microenvironment-related signatures.
CONCLUSIONS: The prevalence of the wound response signature in histologically normal tissue adjacent to breast cancer suggests that microenvironment response is an important variable in breast cancer progression and may be an important target for clinical interventions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887484      PMCID: PMC2783932          DOI: 10.1158/1078-0432.CCR-09-1126

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  49 in total

1.  Adjustment of systematic microarray data biases.

Authors:  Monica Benito; Joel Parker; Quan Du; Junyuan Wu; Dong Xiang; Charles M Perou; J S Marron
Journal:  Bioinformatics       Date:  2004-01-01       Impact factor: 6.937

2.  Morphological evidence of basal keratinocyte migration during the re-epithelialization process.

Authors:  Akihiro Hosoya; Jong-Min Lee; Sung-Won Cho; Ji-Youn Kim; Naoshi Shinozaki; Takahiko Shibahara; Masaki Shimono; Han-Sung Jung
Journal:  Histochem Cell Biol       Date:  2008-09-05       Impact factor: 4.304

Review 3.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

4.  Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases.

Authors:  B A Gusterson; M J Warburton; D Mitchell; M Ellison; A M Neville; P S Rudland
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

5.  Molecular characterization of the tumor microenvironment in breast cancer.

Authors:  Minna Allinen; Rameen Beroukhim; Li Cai; Cameron Brennan; Jaana Lahti-Domenici; Haiyan Huang; Dale Porter; Min Hu; Lynda Chin; Andrea Richardson; Stuart Schnitt; William R Sellers; Kornelia Polyak
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

Review 6.  The role of COX-2 inhibition in breast cancer treatment and prevention.

Authors:  Banu Arun; Paul Goss
Journal:  Semin Oncol       Date:  2004-04       Impact factor: 4.929

7.  A gene-expression signature as a predictor of survival in breast cancer.

Authors:  Marc J van de Vijver; Yudong D He; Laura J van't Veer; Hongyue Dai; Augustinus A M Hart; Dorien W Voskuil; George J Schreiber; Johannes L Peterse; Chris Roberts; Matthew J Marton; Mark Parrish; Douwe Atsma; Anke Witteveen; Annuska Glas; Leonie Delahaye; Tony van der Velde; Harry Bartelink; Sjoerd Rodenhuis; Emiel T Rutgers; Stephen H Friend; René Bernards
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

8.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

Authors:  K M Dameron; O V Volpert; M A Tainsky; N Bouck
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

Review 9.  Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast.

Authors:  Malathy P V Shekhar; Robert Pauley; Gloria Heppner
Journal:  Breast Cancer Res       Date:  2003-02-20       Impact factor: 6.466

10.  Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.

Authors:  Howard Y Chang; Julie B Sneddon; Ash A Alizadeh; Ruchira Sood; Rob B West; Kelli Montgomery; Jen-Tsan Chi; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  PLoS Biol       Date:  2004-01-13       Impact factor: 8.029

View more
  72 in total

1.  Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression.

Authors:  Xuezheng Sun; Patricia Casbas-Hernandez; Carol Bigelow; Liza Makowski; D Joseph Jerry; Sallie Smith Schneider; Melissa A Troester
Journal:  Breast Cancer Res Treat       Date:  2011-10-15       Impact factor: 4.872

2.  Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer.

Authors:  Mauricio P Pinto; Melanie M Badtke; Michelle L Dudevoir; J Chuck Harrell; Britta M Jacobsen; Kathryn B Horwitz
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

3.  Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages.

Authors:  Delisha A Stewart; Yinmeng Yang; Liza Makowski; Melissa A Troester
Journal:  Mol Cancer Res       Date:  2012-04-24       Impact factor: 5.852

4.  Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer.

Authors:  Sneha Sundaram; Alex J Freemerman; Amy R Johnson; J Justin Milner; Kirk K McNaughton; Joseph A Galanko; Katharine M Bendt; David B Darr; Charles M Perou; Melissa A Troester; Liza Makowski
Journal:  Breast Cancer Res Treat       Date:  2013-11-12       Impact factor: 4.872

5.  Colorectal Cancer-Associated Fibroblasts are Genotypically Distinct.

Authors:  Amy A Mrazek; Joseph R Carmical; Thomas G Wood; Mark R Hellmich; Mahmoud Eltorky; Frederick J Bohanon; Celia Chao
Journal:  Curr Cancer Ther Rev       Date:  2014-01

6.  On the diagnosis and treatment of cutaneous and soft tissue tumours misdiagnosed as scars: Lessons from four cases.

Authors:  Yinmin Wang; Feng Yang; Xiao L Wu; Fei Liu; Rui Jin; Chuan Gu; Tao Ni; Xi Wang; Qun Yang; Xusong Luo; Jun Yang
Journal:  Int Wound J       Date:  2019-02-15       Impact factor: 3.315

7.  Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer.

Authors:  Heather Ann Brauer; Liza Makowski; Katherine A Hoadley; Patricia Casbas-Hernandez; Lindsay J Lang; Erick Romàn-Pèrez; Monica D'Arcy; Alex J Freemerman; Charles M Perou; Melissa A Troester
Journal:  Clin Cancer Res       Date:  2012-12-12       Impact factor: 12.531

8.  Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium.

Authors:  Kelly Graham; Xijin Ge; Antonio de Las Morenas; Anusri Tripathi; Carol L Rosenberg
Journal:  Clin Cancer Res       Date:  2010-11-08       Impact factor: 12.531

9.  The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast.

Authors:  Mark E Sherman; Jonine D Figueroa; Jill E Henry; Susan E Clare; Connie Rufenbarger; Anna Maria Storniolo
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-17

10.  Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.

Authors:  Milan Radovich; Susan E Clare; Rutuja Atale; Ivanesa Pardo; Bradley A Hancock; Jeffrey P Solzak; Nawal Kassem; Theresa Mathieson; Anna Maria V Storniolo; Connie Rufenbarger; Heather A Lillemoe; Rachel J Blosser; Mi Ran Choi; Candice A Sauder; Diane Doxey; Jill E Henry; Eric E Hilligoss; Onur Sakarya; Fiona C Hyland; Matthew Hickenbotham; Jin Zhu; Jarret Glasscock; Sunil Badve; Mircea Ivan; Yunlong Liu; George W Sledge; Bryan P Schneider
Journal:  Breast Cancer Res Treat       Date:  2013-11-29       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.